Is Niagen Bioscience, Inc. (NAGE) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 0.7% / 30% | 11.0% / 30% | 1.9% / 30% | 1.13% / 5% | ✓ HALAL |
| DJIM | 0.7% / 33% | 11.0% / 33% | 1.9% / 33% | 1.13% / 5% | ✓ HALAL |
| MSCI | 3.9% / 33% | 65.2% / 33% | 11.4% / 33% | 1.13% / 5% | ✗ NOT HALAL |
| S&P | 0.7% / 33% | 11.0% / 33% | 1.9% / 33% | 1.13% / 5% | ✓ HALAL |
| FTSE | 3.9% / 33% | 65.2% / 33% | 11.4% / 50% | 1.13% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 64.3% | |
| Operating Margin | 6.2% | |
| Net Margin | 13.4% | |
| Return on Equity (ROE) | 28.3% | |
| Return on Assets (ROA) | 10.2% |
Cash Flow & Balance Sheet
| Operating Cash Flow | $14M |
| Free Cash Flow | $13M |
| Total Debt | $3M |
| Debt-to-Equity | 3.7 |
| Current Ratio | 4.9 |
| Total Assets | $106M |
Price & Trading
| Last Close | $4.47 |
| 50-Day MA | $5.25 |
| 200-Day MA | $7.96 |
| Avg Volume | 1.2M |
| Beta | 2.2 |
|
52-Week Range
$4.20
| |
About Niagen Bioscience, Inc. (NAGE)
Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through Consumer products; Ingredients; and Pharmaceutical Segments. It provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that regulates cellular metabolism; and develops and commercializes proprietary-based ingredient technologies, including food-grade, Niagen, and pharmaceutical-grade Niagen and supplies these ingredients as raw materials to the manufacturers of consumer products. In addition, it commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient under NIAGEN brand name. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, and other internet marketplaces, as well as specialty retailers and authorized healthcare practitioners resellers. The company was formerly known as ChromaDex Corporation and changed its name to Niagen Bioscience, Inc. in March 2025. Niagen Bioscience, Inc. was founded in 1999 and is headquartered in Los Angeles, California.
Purification Calculator
As a halal stock with 1.13% impermissible income, you need to purify your dividends.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Niagen Bioscience, Inc. (NAGE) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Niagen Bioscience, Inc. is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Niagen Bioscience, Inc.'s debt ratio?
Niagen Bioscience, Inc.'s debt ratio is 0.7% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 3.9%.
Does Niagen Bioscience, Inc. require dividend purification?
Yes, Niagen Bioscience, Inc. has an impermissible income ratio of 1.13%, which means 1.13% of any dividends received should be donated to charity as purification. This is because a small portion of the company's revenue comes from non-Shariah-compliant sources.
What are Niagen Bioscience, Inc.'s key financial metrics?
Niagen Bioscience, Inc. has a market capitalization of $336M, trailing P/E ratio of 21.0, and revenue of $129M. The company maintains a gross margin of 64.3% and a net margin of 13.4%. Return on equity stands at 28.3%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.